CT
CytoImmune Therapeutics
10/10Traction
The startup develops an integrated ecosystem for biologic and cell therapy technologies, focusing on the commercialization of regenerative medicines through a clinical cell manufacturing facility. This platform enables researchers and biotech companies to access NK cell therapies, enhancing treatment options for cancer patients.
- Biotechnology
Updated 5 months ago
Funding
Raised to date
$37.5MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- The startup develops an integrated ecosystem for biologic and cell therapy technologies, focusing on the commercialization of regenerative medicines through a clinical cell manufacturing facility. This platform enables researchers and biotech companies to access NK cell therapies, enhancing treatment options for cancer patients.